早孕期母体原发巨细胞病毒感染后经绒毛膜绒毛取样PCR诊断先天性感染的可行性研究
前瞻性研究纳入37例早孕期CMV原发感染孕妇,在11-14周行CVS并以绒毛膜绒毛PCR检测病毒基因组,同时以17周后羊水PCR为参考标准。绒毛PCR敏感性50%、特异性100%、阳性预测值100%、阴性预测值91%。结论认为12周后绒毛PCR阴性或可排除CMV相关胚胎病所致后遗症,但需长期随访确认。
要点
- 早孕期CMV原发感染后,CVS绒毛PCR诊断先天性感染的敏感性仅50%,阴性不能完全排除。
- 绒毛PCR特异性100%、阳性预测值100%,阳性结果可确诊胎盘感染。
- 12周后绒毛PCR阴性或可排除CMV相关胚胎病后遗症,但需长期随访验证。
核心结论
- 早孕期母体原发CMV感染后,通过CVS获取绒毛膜绒毛进行CMV基因组PCR扩增可诊断胎盘感染。
- 作者提出12周后绒毛CMV-PCR阴性或可用于排除导致后遗症的CMV相关胚胎病,但需长期随访确认。
研究设计与样本
- 前瞻性研究,2019年10月至2020年10月在Hopital Necker-E.M.妇产科胎儿医学科开展。
- 早孕期CMV血清学筛查后,对CMV原发感染≤10周的孕妇在11-14周行CVS,共37例。
- 对CVS获得的滋养细胞行array-CGH和病毒基因组PCR,所有病例17周后行羊膜腔穿刺并对羊水行PCR。
- 诊断CMV原发感染后即启动伐昔洛韦二级预防以降低垂直传播风险。
- 以羊水PCR为参考标准评估绒毛CMV-PCR的诊断性能。
主要发现
- CVS中位孕周12.7周(范围11.3-14.4周),绒毛CMV-PCR阳性3例、阴性34例。
- 羊膜腔穿刺中位孕周17.6周(范围16.7-29.9周),CVS阳性3例羊水PCR均阳性;CVS阴性34例中羊水PCR阴性31例、阳性3例。
- 绒毛CMV-PCR敏感性50%(95%CI 19-81%),特异性100%(95%CI 89-100%)。
- 阳性预测值100%(95%CI 44-100%),阴性预测值91%(95%CI 77-97%)。
关键数值与推荐
- 以羊水PCR为参考标准,绒毛CMV-PCR敏感性50%(95%CI 19-81%)、特异性100%(95%CI 89-100%)。
- 阳性预测值100%(95%CI 44-100%),阴性预测值91%(95%CI 77-97%)。
- 作者提出12周后绒毛CMV-PCR阴性或可排除CMV相关胚胎病所致后遗症,但需长期随访确认。
临床怎么用
- 早孕期血清学筛查发现CMV原发感染后,可在11-14周行CVS取绒毛行CMV-PCR。
- 绒毛PCR阳性可确诊胎盘感染,特异性与阳性预测值均达100%。
- 绒毛PCR阴性不能排除感染,阴性预测值91%,仍需后续羊水PCR等评估。
- 12周后绒毛PCR阴性或可辅助排除CMV相关胚胎病后遗症,但需长期随访验证。
局限性
- 样本量较小,共37例,阳性仅3例,敏感性置信区间较宽(19-81%)。
- 作者指出12周后绒毛PCR阴性排除后遗症的价值需长期随访评估确认。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the feasibility of amplification of the viral genome by polymerase chain reaction (PCR) analysis of trophoblast samples obtained by chorionic villus sampling (CVS) in cases of maternal primary infection (MPI) with cytomegalovirus (CMV) in early pregnancy. METHODS: This was a prospective study carried out at the Department of Obstetrics and Fetal Medicine, Hopital Necker-E.M., between October 2019 and October 2020. Following CMV serology screening in early pregnancy, CVS was offered to women at 11-14 weeks' gestation after CMV-MPI ≤ 10 weeks. Array-comparative genomic hybridization and amplification of the viral genome by PCR were performed on the trophoblasts obtained by CVS. All cases also underwent amniocentesis from 17 weeks onwards and PCR was performed on the amniotic fluid. Secondary prevention with valacyclovir was initiated as soon as MPI was diagnosed, to decrease the risk of vertical transmission. We evaluated the diagnostic performance of CMV-PCR of trophoblast obtained by CVS, using as the reference standard PCR of amniotic fluid obtained by amniocentesis. RESULTS: CVS was performed in 37 pregnancies, at a median (range) gestational age of 12.7 (11.3-14.4) weeks. CMV-PCR in chorionic villi was positive in three and negative in 34 cases. CMV-PCR following amniocentesis, performed at a median (range) gestational age of 17.6 (16.7-29.9) weeks, was positive for the three cases which were positive following CVS and, of the 34 patients with a negative finding following CVS, amniocentesis was negative in 31 and positive in three. The sensitivity of CMV-PCR analysis of trophoblast obtained by CVS for the diagnosis of CMV, using as the reference standard PCR analysis of amniotic fluid obtained by amniocentesis, was 50% (95% CI, 19-81%), specificity was 100% (95% CI, 89-100%), positive predictive value was 100% (95% CI, 44-100%) and negative predictive value was 91% (95% CI, 77-97%). CONCLUSIONS: Diagnosis of placental infection following MPI in early pregnancy can be achieved by PCR amplification of the CMV genome in chorionic villi. We propose that negative CMV-PCR in the trophoblast after 12 weeks could be used to exclude CMV-related embryopathy leading to sequelae. However, this needs to be confirmed through long-term follow-up evaluation. These findings could help to establish CVS as the diagnostic test of choice following maternal serology screening in early pregnancy. © 2021 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Faure-Bardon V, Fourgeaud J, Guilleminot T, et al. First-trimester diagnosis of congenital cytomegalovirus infection after maternal primary infection in early pregnancy: feasibility study of viral genome amplification by PCR on chorionic villi obtained by CVS. Ultrasound Obstet Gynecol. 2021. PMID: 33533526. doi:10.1002/uog.23608
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。